Cipla

In News

Cipla Receives U.S. FDA Approval for First AB-Rated Generic of Ventolin® HFA - PR Newswire

PR Newswire - Apr 23, 2026

Cipla Receives U.S. FDA Approval For First AB-Rated Generic Of Ventolin® Hfa - TradingView

TradingView - Apr 23, 2026

Cipla Gets USFDA Approval for Albuterol Inhaler, Expands US Respiratory Portfolio - Medical Dialogues

Medical Dialogues - Apr 23, 2026

Cipla Wins U.S. FDA Nod for First AB-Rated Generic Ventolin Inhaler - TipRanks

TipRanks - Apr 23, 2026

Cipla, Sun Pharma recall drugs in US - ETPharma.com

ETPharma.com - Apr 23, 2026

Cipla gets USFDA nod for generic respiratory issues treatment inhalation aerosol - The Economic Times

The Economic Times - Apr 23, 2026

Cipla gains after USFDA nod for generic albuterol inhaler - Business Standard

Business Standard - Apr 23, 2026

Stock Picks Today: Infosys, PVR Inox, Adani Energy, Union Bank, Cipla And More On Brokerages' Radar - NDTV Profit

NDTV Profit - Apr 24, 2026

Cipla jumps nearly 5% after USFDA nod for generic Ventolin inhaler - CNBC TV18

CNBC TV18 - Apr 23, 2026

Cipla Share Price: USFDA ka bada approval, ab GSK ka $1.5 Billion market Cipla ke target par! - Whalesbook

Whalesbook - Apr 23, 2026

Cipla gets USFDA nod for generic respiratory issues treatment inhalation aerosol - BusinessLine

BusinessLine - Apr 23, 2026

Cipla Expands U.S. Respiratory Portfolio with Approval of Nintedanib Capsules (100mg & 150mg) for Idiopathic Pulmonary Fibrosis - BioSpace

BioSpace - Apr 03, 2026

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment